ABSTRACT
About Foot and Mouth Disease Vaccine
FMD is a severe and contagious viral disease found in cloven-hoofed animals. FMD virus leads to illness in cows, sheep, pigs, goats, deer, and other animals with divided hooves. Animals with FMD will have fever and blisters on the tongue, lips, mammary glands, in and around the mouth, and around the hooves. These blisters pop and turn into red areas called erosions. These blisters cause pain and discomfort and will lead to other symptoms such as depression, excessive salivation, anorexia, lameness, and resistance to moving or stand. The disease weakens the animals and will affect the production of meat and milk.
Technavio’s analysts forecast the global foot and mouth disease vaccine market to grow at a CAGR of 8.61% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global foot and mouth disease vaccine market for 2017-2021. To calculate the market size, the report considers the revenue generated through applications such as cattle, pigs, sheep, goats, and others.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Foot and Mouth Disease Vaccine Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Merck
• Brilliant Bio Pharma
• Indian Imumunologicals
• Biogénesis Bagó
• Boehringer Ingelheim
Other prominent vendors
• Bayer HealthCare
• Ceva
• Inovio Pharmaceuticals
• Plumbline Life Sciences
• SEPPIC
Market driver
• Frequent foot-and-mouth disease (FMD) outbreaks in Asia and the Middle East.
• For a full, detailed list, view our report
Market challenge
• Stringent government regulations coupled with adverse side effects.
• For a full, detailed list, view our report
Market trend
• Increasing preventive measures in FMD-free areas.
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Key market highlights
PART 05: An overview of FMD
PART 06: Market landscape
• Market overview
• Five forces analysis
PART 07: Market segmentation by product type
• Conventional vaccines
• Emergency vaccines
PART 08: Market segmentation by application
• Cattle
• Pigs
• Sheep and goats
• Others
PART 09: Geographical segmentation
• FMD vaccines market in APAC
• FMD vaccines market in EMEA
• FMD vaccines market in Americas
PART 10: Decision framework
• PART 11: Drivers and challenges
• Market drivers
• Impact of drivers on key customer segments
• Market challenges
• Impact of challenges on key customer segments
PART 12: Market trends
• Increase in inorganic growth strategies
• Advancements in technology
• Increasing preventive measures in FMD-free areas
PART 13: Vendor landscape
• Competitive scenario
PART 14: Key vendor analysis
• Biogénesis Bagó
• Boehringer Ingelheim
• Brilliant Bio Pharma
• Indian Immunologicals
• Merck
• Other prominent vendors
PART 15: Appendix
• List of abbreviations
List of Exhibits
Exhibit 01: Global FMD vaccines market snapshot
Exhibit 02: Global FMD vaccines market 2016-2021 ($ millions)
Exhibit 03: Opportunity analysis in global FMD vaccines market
Exhibit 04: Five forces analysis
Exhibit 05: Global FMD vaccines market segmentation by vaccine type 2016
Exhibit 06: Global conventional FMD vaccines market 2016-2021 ($ millions)
Exhibit 07: Global emergency FMD vaccines market 2016-2021 ($ millions)
Exhibit 08: Global FMD vaccines market segmentation by application 2016
Exhibit 09: Segmentation of global FMD vaccines market based on geography 2016 and 2021
Exhibit 10: FMD vaccines market revenue by geography 2016-2021 ($ millions)
Exhibit 11: Key countries with FMD occurrence
Exhibit 12: Market scenario in APAC
Exhibit 13: FMD vaccines market in APAC 2016-2021 ($ millions)
Exhibit 14: Key FMD outbreaks in Asian countries
Exhibit 15: Market scenario in EMEA
Exhibit 16: FMD vaccines market in EMEA 2016-2021 ($ millions)
Exhibit 17: Market scenario in Americas
Exhibit 18: FMD vaccines market in Americas 2016-2021 ($ millions)
Exhibit 19: Impact of drivers
Exhibit 20: Impact of challenges
Exhibit 21: Competitive structure analysis of global FMD vaccines market 2016
Exhibit 22: Competitive analysis of global FMD vaccines market
Exhibit 23: Strategic success factors of companies in global FMD vaccines market
Exhibit 24: Biogénesis Bagó: Key highlights
Exhibit 25: Biogénesis Bagó: Strength assessment
Exhibit 26: Biogénesis Bagó: Strategy assessment
Exhibit 27: Biogénesis Bagó: Opportunity assessment
Exhibit 28: Boehringer Ingelheim: Key highlights
Exhibit 29: Boehringer Ingelheim: Strength assessment
Exhibit 30: Boehringer Ingelheim: Strategy assessment
Exhibit 31: Boehringer Ingelheim: Opportunity assessment
Exhibit 32: Brilliant Bio Pharma: Strength assessment
Exhibit 33: Brilliant Bio Pharma: Strategy assessment
Exhibit 34: Brilliant Bio Pharma: Opportunity assessment
Exhibit 35: Indian Immunologicals: Key highlights
Exhibit 36: Indian Immunologicals: Strength assessment
Exhibit 37: Indian Immunologicals: Strategy assessment
Exhibit 38: Indian Immunologicals: Opportunity assessment
Exhibit 39: Merck: Key highlights
Exhibit 40: Merck: Strength assessment
Exhibit 41: Merck: Strategy assessment
Exhibit 42: Merck: Opportunity assessment
